 |
 Video: What is a Stock Split?
|
|
|
| Third Harmonic Bio is a clinical-stage biopharmaceutical company which engages in the development of the medicine for the treatment of allergic and inflammatory diseases. According to our THRD split history records, Third Harmonic Bio has had 1 split. | |
|
Third Harmonic Bio (THRD) has 1 split in our THRD split history database. The split for THRD took place on February 11, 2011. This was a 105 for 100 split, meaning for each 100 shares of THRD owned pre-split, the shareholder now owned 105 shares. For example, a 1000 share position pre-split, became a 1050 share position following the split.
When a company such as Third Harmonic Bio splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the THRD split history from start to finish, an original position size of 1000 shares would have turned into 1050 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Third Harmonic Bio shares, starting with a $10,000 purchase of THRD, presented on a split-history-adjusted basis factoring in the complete THRD split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/14/2022 |
|
| End date: |
10/08/2024 |
|
| Start price/share: |
$17.00 |
|
| End price/share: |
$12.42 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-26.94% |
|
| Average Annual Total Return: |
-14.08% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$7,305.91 |
|
| Years: |
2.07 |
|
|
|
| Date |
Ratio |
| 02/11/2011 | 105 for 100 |
|
|
Free THRD Email Alerts:
